Gamida Cell falls after Q3 revenue miss [Seeking Alpha]
Gamida Cell Ltd. - Ordinary Shares (GMDA)
Last gamida cell ltd. - ordinary shares earnings: 11/13 04:01 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
In April, the FDA greenlighted Gamida's ( GMDA ) allogenic cell therapy Omisirge as a treatment to cut the risk of infections in blood cancer patients who are undergoing umbilical cord blood transplantation. During the quarter, Gamida Cell ( GMDA ) delivered two units of Omisirge, and for the full year, the company expects to recognize revenue from another 2-4 units. It onboarded 17 transplant centers during Q3, exceeding the 2023 target of 10–15. "We anticipate continuing to onboard additional transplant centers, leading to a ramp-up of patients and Omisirge deliveries in the coming months," CEO Abbey Jenkins said. However, GMDA's revenue for the quarter reached only $0.7M, missing average analyst estimates by $1.7M as its lean launch efforts continue into 2024 due to resource constraints. Updating on its ongoing strategic review, Gamida Cell ( GMDA ) said that despite receiving multiple oral and written proposals, it has yet to identify a suitable partner to support Omisirg
Show less
Read more
Impact Snapshot
Event Time:
GMDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMDA alerts
High impacting Gamida Cell Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics